Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

Dec 01, 2014

Mylan and Canadian AIDS Society Team up in Cross-Country Relay to Accelerate Canada's Fight Against HIV/AIDS

Dec 01, 2014

Mylan Signs Agreement with Gilead to Enhance Access to Tenofovir Alafenamide (TAF)-based HIV Treatments in Developing Countries

Nov 25, 2014

Mylan Confirms First-to-File Patent Challenge Relating to BREVIBLOC®

Nov 07, 2014

Mylan Signs Strategic Alliance Agreement with Walt Disney Parks and Resorts to Enhance Access to EpiPen® (epinephrine) Auto-Injectors

Nov 05, 2014

Mylan Launches Generic Loestrin 24 Fe®

Oct 30, 2014

Mylan Third Quarter 2014 Adjusted Diluted EPS Increases 41% to $1.16

Oct 30, 2014

Mylan Launches Generic Viramune XR®

Oct 27, 2014

EpiPen4Schools® Program Enhances Support of National Movement to Improve Anaphylaxis Preparedness and Access to Emergency Treatment in Schools

Oct 06, 2014

Mylan Launches Generic Combivir®

Oct 03, 2014

Mylan Increases Third Quarter and Full Year 2014 Adjusted Diluted EPS Guidance Range

Pagination

First page
Previous page
…
Page 40
Page 41
Page 42
Page 43
Current page 44
Page 45
Page 46
Page 47
Page 48
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2025 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.